XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statement of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
[2]
Common Stock [Member]
Preferred Stock [Member]
Capital Surplus [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
[2]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total U.S. Bancorp Shareholders' Equity [Member]
Total U.S. Bancorp Shareholders' Equity [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
[2]
Noncontrolling Interests [Member]
Beginning Balance at Dec. 31, 2021 $ 55,387   $ 21 $ 6,371 $ 8,539 $ 69,201   $ (27,271) $ (1,943) $ 54,918   $ 469
Shares, Beginning Balance at Dec. 31, 2021     1,484                  
Net income (loss) 1,558         1,557       1,557   1
Other comprehensive income (loss) (4,995)               (4,995) (4,995)    
Preferred stock dividends [1] (84)         (84)       (84)    
Common stock dividends (687)         (687)       (687)    
Issuance of preferred stock 437     437           437    
Issuance of common and treasury stock 16       (116)     132   16    
Issuance of common and treasury stock, shares     3                  
Purchase of treasury stock (54)             (54)   (54)    
Purchase of treasury stock, shares     (1)                  
Distributions to noncontrolling interests (2)                     (2)
Stock option and restricted stock grants 92       92         92    
Shares, Ending Balance at Mar. 31, 2022     1,486                  
Ending Balance at Mar. 31, 2022 51,668   $ 21 6,808 8,515 69,987   (27,193) (6,938) 51,200   468
Beginning Balance at Dec. 31, 2022 51,232 $ 46 $ 21 6,808 8,712 71,901 $ 46 (25,269) (11,407) 50,766 $ 46 466
Shares, Beginning Balance at Dec. 31, 2022     1,531                  
Net income (loss) 1,704         1,698       1,698   6
Other comprehensive income (loss) 1,254               1,254 1,254    
Preferred stock dividends [3] (98)         (98)       (98)    
Common stock dividends (740)         (740)       (740)    
Issuance of common and treasury stock 6       (114)     120   6    
Issuance of common and treasury stock, shares     3                  
Purchase of treasury stock (44)             (44)   (44)    
Purchase of treasury stock, shares     (1)                  
Distributions to noncontrolling interests (7)                     (7)
Stock option and restricted stock grants 101       101         101    
Shares, Ending Balance at Mar. 31, 2023     1,533                  
Ending Balance at Mar. 31, 2023 $ 53,454   $ 21 $ 6,808 $ 8,699 $ 72,807   $ (25,193) $ (10,153) $ 52,989   $ 465
[1] Reflects dividends declared per share on the Company’s Series A, Series B, Series J, Series K, Series L, Series M, Series N and Series O Non-Cumulative Perpetual Preferred Stock of $875.00, $218.75, $662.50, $343.75, $234.375, $250.00, $231.25 and $206.25 respectively.
[2] Effective January 1, 2023, the Company adopted accounting guidance which removed the separate recognition and measurement of troubled debt restructurings. Upon adoption, the Company reduced its allowance for credit losses and increased retained earnings net of deferred taxes through a cumulative-effect adjustment.
[3] Reflects dividends declared per share on the Company’s Series A, Series B, Series J, Series K, Series L, Series M, Series N and Series O Non-Cumulative Perpetual Preferred Stock of $1,462.428, $339.357, $662.50, $343.750, $234.375, $250.00, $231.25 and $281.25 respectively.